Literature DB >> 23833288

Killing two birds with one stone, maybe: CETP inhibition increases both high-density lipoprotein levels and insulin secretion.

Sergio Fazio, MacRae F Linton.   

Abstract

Entities:  

Keywords:  CETP inhibitors; Editorials; HDL; beta cell; insulin

Mesh：

Substances：

Year:  2013        PMID： 23833288      PMCID： PMC3953452          DOI： 10.1161/CIRCRESAHA.113.301832

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  27 in total

1.  Plasma cholesteryl ester transfer protein activity is not linked to insulin sensitivity.

Authors:  P S Maclean; C J Tanner; J A Houmard; H A Barakat
Journal:  Metabolism       Date:  2001-07       Impact factor: 8.694

2.  A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion.

Authors:  R L Dobbins; M W Chester; B E Stevenson; M B Daniels; D T Stein; J D McGarry
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

3.  Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion.

Authors:  Andrew L Siebel; Alaina K Natoli; Felicia Y T Yap; Andrew L Carey; Medini Reddy-Luthmoodoo; Dmitri Sviridov; Chek Ing Kiu Weber; Georgina Meneses-Lorente; Cyrille Maugeais; Josephine M Forbes; Bronwyn A Kingwell
Journal:  Circ Res       Date:  2013-05-15       Impact factor: 17.367

4.  A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone.

Authors:  Mehmood A Khan; John V St Peter; Jay L Xue
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

5.  Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.

Authors:  M S Wu; P Johnston; W H Sheu; C B Hollenbeck; C Y Jeng; I D Goldfine; Y D Chen; G M Reaven
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

6.  Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study.

Authors:  W Bao; S R Srinivasan; G S Berenson
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

7.  Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.

Authors:  G Mingrone; F L Henriksen; A V Greco; L N Krogh; E Capristo; A Gastaldelli; M Castagneto; E Ferrannini; G Gasbarrini; H Beck-Nielsen
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

Review 8.  Diabetic dyslipidemia.

Authors:  Tina J Chahil; Henry N Ginsberg
Journal:  Endocrinol Metab Clin North Am       Date:  2006-09       Impact factor: 4.741

9.  Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.

Authors:  Liam R Brunham; Janine K Kruit; Terry D Pape; Jenelle M Timmins; Anne Q Reuwer; Zainisha Vasanji; Brad J Marsh; Brian Rodrigues; James D Johnson; John S Parks; C Bruce Verchere; Michael R Hayden
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

Review 10.  Banting lecture 1990. Beta-cells in type II diabetes mellitus.

Authors:  D Porte
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461
View more
  5 in total

Review 1.  Lipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well?

Authors:  Rohit B Sharma; Laura C Alonso
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

Review 2.  HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review.

Authors:  Emilie W Kjeldsen; Liv T Nordestgaard; Ruth Frikke-Schmidt
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 3.  The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.

Authors:  Marek Femlak; Anna Gluba-Brzózka; Aleksandra Ciałkowska-Rysz; Jacek Rysz
Journal:  Lipids Health Dis       Date:  2017-10-30       Impact factor: 3.876

4.  CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet.

Authors:  Lin Zhu; Thao Luu; Christopher H Emfinger; Bryan A Parks; Jeanne Shi; Elijah Trefts; Fenghua Zeng; Zsuzsanna Kuklenyik; Raymond C Harris; David H Wasserman; Sergio Fazio; John M Stafford
Journal:  Diabetes       Date:  2018-09-13       Impact factor: 9.461

5.  Obesity-associated metabolites in relation to type 2 diabetes risk: A prospective nested case-control study of the CARRS cohort.

Authors:  Mohammed K Ali; M Masood Kadir; Unjali P Gujral; Syeda Sadia Fatima; Romaina Iqbal; Yan V Sun; K M Venkat Narayan; Shafqat Ahmad
Journal:  Diabetes Obes Metab       Date:  2022-07-05       Impact factor: 6.408
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.